Biohit Oyj Statistics
Biohit Oyj (0DRP) Stock Statistics & Valuation Metrics
Total Valuation
Biohit Oyj has a market cap or net worth of EUR 32.08M. The enterprise value is EUR 41.56M.
- Market Cap
- EUR 32.08M
- Enterprise Value
- EUR 41.56M
Share Statistics
Biohit Oyj has 12,230,093 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 12,230,093
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Biohit Oyj’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 18.07%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.17
- Return on Invested Capital (ROIC)
- 18.07%
- Return on Capital Employed (ROCE)
- 0.21
- Revenue Per Employee
- 304.26K
- Profits Per Employee
- 55.32K
- Employee Count
- 47
- Asset Turnover
- 0.92
- Inventory Turnover
- 5.00
Valuation Ratios
The current PE Ratio of Biohit Oyj is 39.30. Biohit Oyj’s PEG ratio is -0.28.
- PE Ratio
- 39.30
- PS Ratio
- 2.16
- PB Ratio
- 3.17
- Price to FCF
- 13.20
- Price to Operating Cash Flow
- 12.78
- PEG Ratio
- -0.28
Income Statement
In the last 12 months, Biohit Oyj had revenue of 14.30M and earned 2.60M in profits. Earnings per share was 0.17.
- Revenue
- 14.30M
- Gross Profit
- 9.30M
- Operating Income
- 2.60M
- Pretax Income
- 2.90M
- Net Income
- 2.60M
- EBITDA
- 3.50M
- Earnings Per Share (EPS)
- 0.17
Cash Flow
In the last 12 months, operating cash flow was 600.00K and capital expenditures -400,000, giving a free cash flow of 200.00K billion.
- Operating Cash Flow
- 600.00K
- Free Cash Flow
- 200.00K
- Free Cash Flow per Share
- 0.12
Dividends & Yields
Biohit Oyj pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.57%
- Earnings Yield
- 2.54%
Stock Price Statistics
- Beta
- 1.13
- 52-Week Price Change
- -36.47%
- 50-Day Moving Average
- 2.29
- 200-Day Moving Average
- 2.50
- Relative Strength Index (RSI)
- 45.54
- Average Volume (3m)
- 563
Important Dates
Biohit Oyj upcoming earnings date is Feb 17, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- Feb 17, 2027
- Ex-Dividend Date
- ―
Financial Position
Biohit Oyj as a current ratio of 3.67, with Debt / Equity ratio of 4.88%
- Current Ratio
- 3.67
- Quick Ratio
- 3.33
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.88
- Interest Coverage Ratio
- 8.67
Taxes
In the past 12 months, Biohit Oyj has paid 300.00K in taxes.
- Income Tax
- 300.00K
- Effective Tax Rate
- 0.10
Enterprise Valuation
Biohit Oyj EV to EBITDA ratio is 16.72, with an EV/FCF ratio of 12.54.
- EV to Sales
- 2.05
- EV to EBITDA
- 16.72
- EV to Free Cash Flow
- 12.54
- EV to Operating Cash Flow
- 12.14
Balance Sheet
Biohit Oyj has EUR 6.70M in cash and marketable securities with EUR 600.00K in debt, giving a net cash position of EUR 6.10M billion.
- Cash & Marketable Securities
- EUR 6.70M
- Total Debt
- EUR 600.00K
- Net Cash
- EUR 6.10M
- Net Cash Per Share
- EUR 0.50
- Tangible Book Value Per Share
- EUR 0.80
Margins
Gross margin is 64.93%, with operating margin of 7.87%, and net profit margin of 5.49%.
- Gross Margin
- 64.93%
- Operating Margin
- 7.87%
- Pretax Margin
- 7.93%
- Net Profit Margin
- 5.49%
- EBITDA Margin
- 12.25%
- EBIT Margin
- 10.31%
Analyst Forecast
The average price target for Biohit Oyj is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 12.59%
- EPS Growth Forecast
- 40.79%

